Penta‑backed Dôvera to acquire Union, creating potential health‑insurance duopoly in Slovakia

The private health insurer Dôvera, owned by the investment group Penta, has signed a share‑transfer agreement with Union’s shareholder Achmea B.V. to acquire Union’s business. The transaction, signed on 14 July, will be financed entirely from Dôvera’s own funds and will not use money earmarked for health‑care payments.

Regulatory approval is still required from the Office for Supervision of Health Care and the Slovak Antimonopoly Office. If approved, Union will continue to operate independently until the end of 2026, after which the two firms will merge under the Dôvera brand.

Union currently covers about 980 000 people (≈10 % of the market), Dôvera about 1.8 million (≈35 %), and the state insurer Všeobecná zdravotná poisťovňa about 2.7 million (≈52 %). After the merger, Dôvera would control roughly 48 % of private health‑insurance enrolments, leaving only the state insurer as a major competitor. Opposition parties and health‑care unions warn that the deal could create a de‑facto duopoly, limiting patient choice and bargaining power. SaS MP Tomáš Szalay said, “The merger will create a factual duopoly.” Peter Visolajský, head of the doctors’ union, called the concentration “harmful in every sphere for consumers and public finances.”

Company executives say the merger will not affect existing Union customers; services, benefits and provider contracts will remain unchanged for the time being, and the combined entity plans to offer a broader range of services. Critics, however, stress the risk that a single private group owning both an insurer and a large network of hospitals, pharmacies and clinics could exert excessive influence over the health‑care system.